Literature DB >> 11167282

Is it mandatory to treat amblyopia prior to surgery in esotropia?

S Dadeya1, M S Kamlesh.   

Abstract

PURPOSE: To determine whether presence of amblyopia has any influence on the outcome of motor and sensory success in cases of esotropia.
METHODS: 100 patients were taken for this study. Patients were divided into two groups of 50 each. Amblyopia was fully treated in group I and patients in group II underwent surgery before full treatment of amblyopia. Motor success (+/- 10 PD of orthophoria) was assessed three months after surgery and at the child's most recent visit by comparing the motor alignment at 6 meter and 0.33 meter distance using accommodative target in primary position. Sensory success was assessed by comparing the frequency of detectable stereoacuity.
RESULTS: There was no significant difference in motor success (84% vs 75%) and sensory success (55% vs 50%) whether amblyopia was fully treated or partially treated.
CONCLUSION: It is not mandatory to treat ambloypia prior to surgery, unless it is a case of infantile esotropia with moderate amblyopia and amblyopia therapy is continued post operatively.

Entities:  

Mesh:

Year:  2001        PMID: 11167282     DOI: 10.1034/j.1600-0420.2001.079001028.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  3 in total

1.  The effect of amblyopia therapy on ocular alignment.

Authors:  Michael X Repka; Jonathan M Holmes; B Michele Melia; Roy W Beck; Matthew D Gearinger; Susanna M Tamkins; David T Wheeler
Journal:  J AAPOS       Date:  2005-12       Impact factor: 1.220

2.  Strabismus surgery before versus after completion of amblyopia therapy in children.

Authors:  Sanita Korah; Swetha Philip; Smitha Jasper; Aileen Antonio-Santos; Andrew Braganza
Journal:  Cochrane Database Syst Rev       Date:  2014-10-15

Review 3.  Management of amblyopia in pediatric patients: Current insights.

Authors:  Sagnik Sen; Pallavi Singh; Rohit Saxena
Journal:  Eye (Lond)       Date:  2021-07-07       Impact factor: 3.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.